Transactions
Oct. 24, 2000
Wilson Sonsini: HAYWARD GENETICS COMPANY GIVES LIFE TO $70 MILLION IPO
Hayward's Kosan Biosciences Inc. has gone public in an offering valued at $70 million. Kosan Biosciences is a development-stage genetics company that improves existing pharmaceuticals and develops new ones. Its gene manipulation process mimics, accelerates and expands the evolutionary process.




Kosan Biosciences is a development-stage genetics company that improves existing pharmaceuticals and develops new ones. Its gene manipulation process mimics, accelerates and expands the evolutionary process. Kosan's products include antibiotics, anti-cancer drugs, cholesterol-lowering drugs, i...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In